je.st
news
Tag: bio
Bio PE a natural choice for renewable barrier coating
2013-12-17 17:56:40| Paper - Topix.net
Stora Enso has said that bio-polyethylene is the natural choice to replace current barrier coating methods as it builds to fully renewable products.
Tags: natural
choice
bio
barrier
BIO Thanks Rep. Scott Peters (D-CA) for Legislation to Extend Current Tax Policies
2013-12-16 06:00:00| Industrial Newsroom - All News for Today
BIO expressed thanks to Rep. Scott Peters (D-CA) for introducing the Second Generation Biofuel Extension Act of 2013, which provides a 1-year extension of the Second Generation Biofuel Producer Credit and the Special Allowance for Second Generation Biofuel Plant Property. According to Brent Erickson, EVP of BIO's Industrial & Environmental Section, extension of these tax provisions is needed to keep the playing field level for advanced biofuel companies commercializing innovative ...This story is related to the following:Green & CleanSearch for suppliers of:
Tags: current
policies
tax
scott
BIO Supports Budget Action to Free up FDA User Fees
2013-12-13 06:00:00| Industrial Newsroom - All News for Today
BIO applauded House of Representatives for passing bipartisan budget deal that raises discretionary budget caps, which should provide FDA with complete access to its user fees for fiscal years 2014 and 2015. Thus commending Congress, BIO President and CEO Jim Greenwood noted "the forward-thinking action" and called on House and Senate to pass both S. 1413, Pryor/Blunt FDA User Fee Protection Act, and H.R. 2725, Lance/Eshoo FDA SOS Act, to ensure FDA user fees are never again sequestered. This story is related to the following:Trade Associations
DuPont Tate & Lyle Bio Products Selects Archway Sales to Distribute its Susterra 1,3-PDO in ...
2013-12-12 06:00:00| Coatings World Breaking News
Tags: products
sales
bio
distribute
OncoMed Pharmaceuticals CEO Testifies on Behalf of BIO at Congressional Hearing on FDA Drug ...
2013-12-12 06:00:00| Industrial Newsroom - All News for Today
House Committee on Oversight & Government Reform, Subcommittee on Energy Policy, Health Care & Entitlements held a hearing entitled, "FDA Check-Up: Drug Development and Manufacturing Challenges." Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals and Chairman of BIO’s Emerging Companies Section Governing Board, presented testimony emphasizing the positive indicators that demonstrate the biopharma industry is rebounding, but significant financial and regulatory challenges ...This story is related to the following:Green & CleanSearch for suppliers of:
Sites : [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] next »